Research
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39555.441944.BE (Published 29 May 2008) Cite this as: BMJ 2008;336:1227Data supplement
Web extras
Web extras
Files in this Data Supplement:
- Web tables - Web tables
- Web references - Web references
Related articles
- Editorial Published: 29 May 2008; BMJ 336 doi:10.1136/bmj.39556.666944.80
- ResearchTransdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control studyPublished: 04 June 2010; BMJ 340 doi:10.1136/bmj.c2519
- Clinical Review Published: 08 February 2003; BMJ 326 doi:10.1136/bmj.326.7384.322
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Research Published: 24 February 2011; BMJ 342 doi:10.1136/bmj.d813
- Research Published: 16 August 2011; BMJ 343 doi:10.1136/bmj.d4656
- Clinical Review Published: 17 July 2014; BMJ 349 doi:10.1136/bmj.g4387
See more
- Whole brain radiotherapy for brain metastasesBMJ December 05, 2016, 355 i6483; DOI: https://doi.org/10.1136/bmj.i6483
- Biological treatment is approved for severe eosinophilic asthmaBMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472
- Preserving fertility in girls and young women with cancerBMJ November 30, 2016, 355 i6145; DOI: https://doi.org/10.1136/bmj.i6145
- Glucagon-like peptide-1 receptor agonists and risk of breast cancerBMJ October 20, 2016, 355 i5519; DOI: https://doi.org/10.1136/bmj.i5519
- Anabolic steroid useBMJ October 13, 2016, 355 i5023; DOI: https://doi.org/10.1136/bmj.i5023
Cited by...
- A case vignette describing management of menopausal symptoms and migraine in the perimenopause
- Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons
- Thromboembolism peaking 3 months after starting testosterone therapy: testosterone-thrombophilia interactions
- Stroke Risk Factors Unique to Women
- Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception
- Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
- Deep vein thrombosis in a transgender woman
- Is there a time limit for systemic menopausal hormone therapy?
- Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
- Diagnosis and management of heritable thrombophilias
- Sex Difference in Risk of Second but Not of First Venous Thrombosis: Paradox Explained
- Computed Tomography of Pulmonary Embolism
- Mechanistic View of Risk Factors for Venous Thromboembolism
- Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
- Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
- Herbal medicines for menopausal symptoms
- Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
- Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
- Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism: Results From the E3N Cohort Study
- Patch Instead of Pill: A Safer Menopausal Estrogen?
- Update on acute pulmonary embolism
- Drospirenone in HRT?
- Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
- Herbal medicines for menopausal symptoms
- Hormone Therapy and Risk for Venous Thromboembolism
- Type of hormone replacement therapy and risk of venous thromboembolism